David W Osborne Net Worth & Insider Trades

David W Osborne - Chief Technical Officer, Arcutis Biotherapeutics, Inc

As of March 8, 2023

What is David W Osborne's Net Worth?

The current estimated net worth of Arcutis Biotherapeutics, Inc's Chief Technical Officer, David W Osborne, is estimated to be about $1.61M . David W Osborne owns about 268,854 units of Arcutis Biotherapeutics, Inc common stock. In the last 3 years at Arcutis Biotherapeutics, Inc, David W Osborne has sold an estimated value of $1.1M worth.

What is David W Osborne's Past Insider Trading?

David W Osborne's largest sale order was 15,000 units , worth over $450K on December 16, 2020. In total, David W Osborne has made about 13 transactions over 3 years of their time at Arcutis Biotherapeutics, Inc. David W Osborne usually trades in March, with the busiest year in 2022 and 2020. The most recent transaction was a sale order of 690 units , worth over $10.53K on March 8, 2023.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

David W Osborne

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Arcutis Biotherapeutics, Inc's Past Insider Trades?

Arcutis Biotherapeutics, Inc's most recent insider trade came on December 1, 2023 by Todd Franklin Watanabe who bought 60,988 units worth $109.37K . In the last 3 years, insiders at Arcutis Biotherapeutics, Inc have sold an estimated value of $34.06M and bought an estimated value of $71.83M worth of shares. Insider trading is most common in March, with the busiest year in 2021. The most active traders at the company are Howard Welgus, Director,  Todd Franklin Watanabe, See Remarks,  and David W Osborne, Chief Technical Officer .

Arcutis Biotherapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...